Published • loading... • Updated
IBRX SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of ImmunityBio, Inc. Investors ...
The suit says ImmunityBio kept promoting Anktiva after the FDA called a TV ad and podcast false or misleading, sending shares down 21.2%.
Summary by Hastings Tribune
4 Articles
4 Articles
IBRX SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of ImmunityBio, Inc. Investors
NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased ImmunityBio, Inc. ("ImmunityBio" or the "Company") (NASDAQ:IBRX) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at , or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost. If you suffered a loss on your ImmunityBio investments, you have until May 26, 2026…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources4
Leaning Left0Leaning Right0Center4Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
